MP12-05 AN ANALYSIS OF THE RURAL-URBAN DISPARITY IN MUSCLE-INVASIVE BLADDER CANCER USING A STATE CANCER REGISTRY

Abstract

You have accessJournal of UrologyGeneral & Epidemiological Trends & Socioeconomics: Practice Patterns, Quality of Life and Shared Decision Making II (MP12)1 Apr 2020MP12-05 AN ANALYSIS OF THE RURAL-URBAN DISPARITY IN MUSCLE-INVASIVE BLADDER CANCER USING A STATE CANCER REGISTRY Anup Shah*, Kelly Pekala, ZhaoJun Sun, Kirsten Eom, Benjamin Davies, Jie Li, Lindsay Sabik, and Bruce Jacobs Anup Shah*Anup Shah* More articles by this author , Kelly PekalaKelly Pekala More articles by this author , ZhaoJun SunZhaoJun Sun More articles by this author , Kirsten EomKirsten Eom More articles by this author , Benjamin DaviesBenjamin Davies More articles by this author , Jie LiJie Li More articles by this author , Lindsay SabikLindsay Sabik More articles by this author , and Bruce JacobsBruce Jacobs More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000832.05AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Rural and urban disparities exist in genitourinary cancer. This disparity may result from numerous health determinants and ultimately impacts stage at diagnosis and treatment. Our objective was to examine the impact of rural residence on survival among patients with muscle-invasive bladder cancer using a state-wide cancer registry. METHODS: Using the Pennsylvania Cancer Registry, which collects demographic, insurance, and clinical information of every patient with cancer within the state, we identified all patients diagnosed with non-metastatic muscle invasive bladder cancer between 2010-2016 based on clinical and pathologic TNM staging. We stratified patients based on counties of residence according Rural-Urban Commuting Area (RUCA) classification into urban, large town, and rural. We calculated overall survival for patients based on rurality of their residence. RESULTS: We identified 3,362 cases of non-metastatic muscle-invasive bladder cancer of which 2,870 cases (85.4%) were urban, 320 cases (9.5%) were large towns, and 172 cases (5.1%) were rural. The median age at diagnosis was 73 years. The rate of new diagnosis was consistent over the study period. The overall survival was similar for urban, large town, and rural residents with 13.64, 13.51, and 14.01 months respectively. Approximately 34% of the study population had survival of less than 6 months, whereas 41% had a survival of 6-18 months and 25% had survival for >18 months. CONCLUSIONS: There was not a clinically significant survival difference for patients with non-metastatic muscle-invasive bladder cancer based on rurality of residence. The overall median survival was just over one year. Whether this is a reflection of individual tumor characteristics, the effects of centralization or underutilization of definitive therapy within this cohort is an area of further investigation. Source of Funding: Shadyside Hospital Foundation © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 203Issue Supplement 4April 2020Page: e146-e146 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Anup Shah* More articles by this author Kelly Pekala More articles by this author ZhaoJun Sun More articles by this author Kirsten Eom More articles by this author Benjamin Davies More articles by this author Jie Li More articles by this author Lindsay Sabik More articles by this author Bruce Jacobs More articles by this author Expand All Advertisement PDF downloadLoading ...